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Abstract
The histone methyltransferase SU(VAR)3–9 plays an important role in the formation of heterochromatin
within the eukaryotic nucleus. Several studies have shown that the formation of condensed chromatin is
highly regulated during development, suggesting that SU(VAR)3–9's activity is regulated as well. However, no
mechanism by which this may be achieved has been reported so far. As we and others had shown previously
that the N-terminus of SU(VAR)3–9 plays an important role for its activity, we purified interaction partners
from Drosophila embryo nuclear extract using as bait a GST fusion protein containing the SU(VAR)3–9 N-
terminus. Among several other proteins known to bind Su(VAR)3–9 we isolated the chromosomal kinase
JIL-1 as a strong interactor. We show that SU(VAR)3–9 is a substrate for JIL-1 in vitro as well as in vivo and
map the site of phosphorylation. These findings may provide a molecular explanation for the observed genetic
interaction between SU(VAR)3–9 and JIL-1.
Disciplines
Biochemistry, Biophysics, and Structural Biology | Genetics | Molecular Biology | Molecular Genetics
Comments
This article is published as Boeke J, Regnard C, Cai W, Johansen J, Johansen KM, Becker PB, et al. (2010)
Phosphorylation of SU(VAR)3–9 by the Chromosomal Kinase JIL-1. PLoS ONE 5(4): e10042. doi:
10.1371/journal.pone.0010042.
Creative Commons License
Creative
Commons
Attribution
4.0
License
This work is licensed under a Creative Commons Attribution 4.0 License.
Authors
Joern Boeke, Catherine Regnard, Weili Cai, Jorgen Johansen, Kristen M. Johansen, Peter B. Becker, and Axel
Imhof
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/bbmb_ag_pubs/228
Phosphorylation of SU(VAR)3–9 by the Chromosomal
Kinase JIL-1
Joern Boeke1, Catherine Regnard1, Weili Cai2, Jørgen Johansen2, Kristen M. Johansen2, Peter B. Becker1,
Axel Imhof1*
1Adolf-Butenandt Institute and Munich Center of Integrated Protein Science (CIPS), Ludwig Maximilians University of Munich, Munich, Germany, 2Department of
Biochemistry, Biophysics & Molecular Biology, Iowa State University, Ames, Iowa, United States of America
Abstract
The histone methyltransferase SU(VAR)3–9 plays an important role in the formation of heterochromatin within the
eukaryotic nucleus. Several studies have shown that the formation of condensed chromatin is highly regulated during
development, suggesting that SU(VAR)3–9’s activity is regulated as well. However, no mechanism by which this may be
achieved has been reported so far. As we and others had shown previously that the N-terminus of SU(VAR)3–9 plays an
important role for its activity, we purified interaction partners from Drosophila embryo nuclear extract using as bait a GST
fusion protein containing the SU(VAR)3–9 N-terminus. Among several other proteins known to bind Su(VAR)3–9 we isolated
the chromosomal kinase JIL-1 as a strong interactor. We show that SU(VAR)3–9 is a substrate for JIL-1 in vitro as well as in
vivo and map the site of phosphorylation. These findings may provide a molecular explanation for the observed genetic
interaction between SU(VAR)3–9 and JIL-1.
Citation: Boeke J, Regnard C, Cai W, Johansen J, Johansen KM, et al. (2010) Phosphorylation of SU(VAR)3–9 by the Chromosomal Kinase JIL-1. PLoS ONE 5(4):
e10042. doi:10.1371/journal.pone.0010042
Editor: Laszlo Tora, Institute of Genetics and Molecular and Cellular Biology, France
Received February 10, 2010; Accepted March 17, 2010; Published April 6, 2010
Copyright:  2010 Boeke et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Work in the Imhof and Becker labs is supported by grants from the Deutsche Forschungsgemeinschaft [IM 23/4-3 and SFB-TR5 accordingly]. Work in
the Johansen laboratory is supported by a grant from the National Institutes of Health [GM62916]. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: AI is an academic editor for PLoS ONE.
* E-mail: Imhof@lmu.de
Introduction
The modifications of specific residues within the histone N-
termini serve as a marking system that contributes to the
establishment and maintenance of distinct chromatin structures
[1,2,3,4]. Modified amino acids are recognized by chromatin-
binding factors that distinguish between differentially modified
histones [5,6,7] and are involved in the organization of chromatin
[8,9]. Proteins that interact with modified histones can also be
regulated themselves by posttranslational modifications [10]. For
example HP1, the well-known binding factor for histone H3
methylated at lysine 9 (H3K9me), is phosphorylated at multiple
sites [11,12,13]. These phosphorylations appear to be necessary
for its biological function to set up a characteristic heterochromatic
structure [11,14]. Surprisingly little is known about the regulation
of the enzymes that catalyze the formation of the posttranslational
modifications. The histone methyltransferases Suv39H1 and
ENX2 are phosphorylated in vivo [15,16], but the exact position,
the regulation or the biological function of the modification has so
far remained elusive. Only recently several groups showed that
distinct signaling pathways could indeed modulate methyltrans-
ferase function [17,18,19]. Besides phosporylation, histone meth-
yltransferases are able to catalyze their own auto-methylation,
which has been suggested to regulate their activity [20]. However,
the biological function of this modification remains unclear.
One of the best-characterized chromatin structures in vivo is the
pericentric constitutive heterochromatin [21]. In a popular model
system for monitoring the repressive effect of heterochromatin,
active genes are juxtaposed to pericentric heterochromatin by a
large chromosomal inversion. Thereby the expression of these
genes becomes sensitive to repression by near-by heterochromatin
[22]. This phenomenon called ‘‘position effect variegation’’ (PEV)
allowed the genetic isolation of suppressors and enhancers of
heterochromatin mediated repression [23]. Until now over 50
different suppressor (Su(var)) or enhancer (E(var)) mutants were
isolated in several laboratories, but only a few of them have been
characterized in detail. Among these are the known chromatin
binding factor HP1 (SU(VAR)2–5) [24] and the histone
methyltransferase SU(VAR)3–9 [25]. Another interesting enzyme
that was isolated as a suppressor of position effect variegation is the
dual kinase JIL-1/SU(VAR)3-1 [26,27]. JIL-1 had initially been
identified as a kinase implicated in dosage compensation of
Drosophila [28]. Besides this rather specific function, mutation of
JIL-1 also has major consequences on global chromosome
structure as it leads to deranged chromosomes [29].
Although several factors involved in heterochromatin formation
have been defined for some time, we are far from understanding
the principles that allow a coordination of heterochromatin
formation with other physiological events such as the cell cycle
or external signals. Here we show that two factors that are
involved in forming specific chromatin structures, the histone
methyltransferase SU(VAR)3–9 and the kinase JIL-1, physically
interact. Furthermore, the chromosomal kinase JIL-1 is able to
phosphorylate SU(VAR)3–9 at a specific residue within the N-
terminus, a region that is important for its function. Our data
together with the recent discovery that JIL-1 genetically interacts
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with Su(var)3–9 but not with Su(var)2–5 [30] suggest that the
phosphorylation of SU(VAR)3–9 may play a role in fine-tuning its
ability to mediate heterochromatin formation and spreading.
Materials and Methods
Plasmids
GST- and His-tagged dSU(VAR)3–9 and dSU(VAR)3–9
deletion constructs were cloned and expressed in bacteria as
described earlier [31]. Constructs for GAL4-DBD fusions of
SU(VAR)3–9 and for the expression of SU(VAR)3–9 in a
baculovirus system were cloned by inserting PCR fragments into
pActGAL4 or pFastBac HTB (details available on request). Two
different expression constructs were used for the expression of
recombinant JIL-1 kinase from Sf9 cells. For GST-JIL(40–1207),
JIL-1 coding sequence from the pGEX 4T3 clone [32] was cloned
into pAcGHLT-A (BD, Biosciences). For JIL(1–1207) expression,
the full length coding sequence was PCR-amplified from the EST
clone AT19088 (BDGP) and cloned into pCRII-TOPO (Invitro-
gen), which was used for in vitro translation of the JIL-1. The full
length sequence was cloned into pVL1392 (Invitrogen) with an N-
terminal flag-tag for expression in Sf9 cells. For the generation of
point mutants of SU(VAR)3–9 and for the Flag-Jil-1D392A mutant,
which is catalytically inactive, mutagenesis was carried out using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene)
(Details are available on request).
Affinity purification of proteins binding to the SU(VAR)3–
9 N-terminus
GST and GST-SU(VAR)3–9NT (aa 1–152) were expressed in
Escherichia coli BL21 and individually bound to GSTrap FF
columns (GE Healthcare). Parallel columns A and B were coupled
with GST and GST SU(VAR)3–9NT respectively, and a Drosophila
nuclear extract from 0–12 hour embryos was loaded. After a
washing step (200 mM NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM
EDTA, 0.5% Nonidet P-40), a step elution (250, 500 and
750 mM) of the bound proteins was conducted on an A¨KTA-
FPLC system (GE Healthcare). Fractions were analyzed for bound
proteins by SDS-PAGE followed by silver staining and/or
Western Blot.
Antibodies
Polyclonal rabbit anti-S191ph antibodies were raised against the
peptide KRRRSS(p)CVGAP (Eurogentec) and subsequently
affinity-purified to enrich for the phospho-specific antibodies.
Monoclonal rat antibodies against SU(VAR)3–9 were described in
[33].
GST pull-down of in vitro translated proteins
GST and GST fusion proteins were expressed in E. coli BL21.
GST pull-downs were carried out essentially as described earlier
[34]. Bacteria were induced with 0.2 mM isopropyl-D-thiogalac-
topyranoside (IPTG) for 3 h at 37uC. Recombinant proteins were
purified with glutathione-sepharose beads (GE Healthcare) and
analyzed by SDS-PAGE to normalize protein amounts. Equiva-
lent amounts of GST fusion proteins were incubated with [35S]-
methionine-labeled proteins, produced by the T7/T3 TNT-
coupled transcription/translation system (Promega) in 200 ml of
binding buffer (100 mM NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM
EDTA, 0.5% Nonidet P-40, 5 mg of ethidium bromide, 100 mg of
bovine serum albumin (BSA)). After 0.5 h of incubation at room
temperature, the beads were washed 5 times with 1 ml of binding
buffer without ethidium bromide and BSA. The bound proteins
were eluted with SDS sample buffer, separated by SDS-PAGE,
and visualized by autoradiography.
Cell Culture and Transfection
Drosophila Schneider cells (SL2) were grown in Schneider’s
Drosophila medium (Gibco) +10% fetal calf serum and transfected
using the Effectene Transfection Reagent (Qiagen) according to
the manufacturer’s instructions. Luciferase reporter assays were
performed essentially as described earlier [35]. To activate the
basal transcription of the pG5DE5-tkluc reporter expression
plasmids for dorsal and twist were cotransfected with the indicated
GAL-fusion proteins and a plasmid carrying the Renilla luciferase
gene under the control of the tk-promotor to normalize
transfection efficiency. After 48 hours the transfected cells were
harvested, lysed and analyzed for luciferase expression using the
Dual-Luciferase Reporter Assay System (Promega). Expression of
the Gal-fusion proteins were monitored by Western blotting by
using an anti-GAL antibody (N19, Santa Cruz Biotechnology).
Kinase assays
Recombinant and purified JIL-1 kinase (GST- or flag-tagged)
were mixed with the indicated substrate proteins in kinase buffer
(20 mM Hepes pH 7.6, 1 mMMgCl2, 1 mM EGTA, 5 mM NaF,
0.1 mM Na3VO4, 10 mM ATP) + [32P]-labeled cATP and
incubated for 30 min at 26uC. The reactions were stopped by
addition of sample buffer and 20–100% of the reactions were
analyzed by SDS-PAGE. After Coomassie staining of the gels, to
visualize equal protein amounts, the SDS-gels were dried and
analyzed on a Phosphoimager.
Immunocytochemistry of co-targeted LacI-Su(var)3–9
and LacI-JIL-1 to polytene chromososomes
The DNA-binding domain of the lacI repressor from E. coli was
fused to the NH2-terminus of the full-length Su(var)3–9 cDNA
inserted in the pUAST vector. LacI-Su(var)3–9 pUAST fly lines
were generated by standard P-element transformation (BestGene,
Inc.). The LacI-JIL-1 and LacI-JIL-1 catalytically inactive pUAST
lines have been described [36] and the Lac operator insertion line
P11.3 was described in [37,38]. Third instar larvae co-expressing
LacI-Su(var)3–9 together with LacI-JIL-1 or with LacI-JIL-1
catalytically inactive protein were generated by standard genetic
crosses with expression driven by the Sgs3-GAL4 driver (obtained
from the Bloomington Stock Center). Acid-free polytene squash
preparations were made and labeled with antibody as described
[39]. Primary antibodies used include rabbit anti-Su(var)3–9
S191ph (this study), rabbit anti-Su(var)3–9 (gift of Dr. G. Reuter),
mouse anti-lacI (Upstate Biotechnology), rabbit anti-JIL-1 [40],
chicken anti-JIL-1 [32], and anti-JIL-1 mAb 5C9 [32]. DNA was
visualized by staining with Hoechst 33258 (Molecular Probes) in
PBS.
Results
The N-terminus of SU(VAR)3–9 plays a crucial role in
regulating the enzyme’s function in vitro [31,41]. As we had
previously shown that it mediates an intramolecular protein-
protein interaction [31], we wondered whether additional proteins
might interact with this domain thereby regulating the function of
the methyltransferase. Therefore we expressed the N-terminus of
SU(VAR)3–9 as a GST-fusion protein in bacteria and used this as
a bait to isolate specific interactors from nuclear extracts of
Drosophila 0–12 hr embryos. Testing candidate factors we found
that among several other known interactors such as HP1 or RPD3,
the chromosomal kinase JIL-1 also interacted specifically with the
JIL1 Phosphorylates SU(VAR)3–9
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Figure 1. Identification of the chromosomal kinase JIL-1 as a novel interaction partner of SU(VAR)3–9. (A) Western Blot analysis of the
eluates (250, 500, 750 mM Nacl and reduced Glutathion, GSH) from the indicated columns, identifies JIL-1 as a novel interactor of SU(VAR)3–9. 15 ml
of each fraction were separated by SDS-PAGE and subjected to Western Blot analysis using the indicated antibodies (FT = flow through). (B) The JIL-1
C-terminus mediates the interaction with SU(VAR)3–9. Top: Schematic representation of the JIL-1 derivatives used for the in vitro translation reaction
indicating the characteristic domain structure of JIL-1 (KD1/KD2 = kinase domain 1 and 2). Bottom: GST pull-downs using bacterially expressed GST
JIL1 Phosphorylates SU(VAR)3–9
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N-terminus of SU(VAR)3–9 (Figure 1A). We did not observe an
interaction with the endogenous SU(VAR)3–9 suggesting that
either the concentration of endogenous SU(VAR)3–9 is too low or
that it is entirely involved in interactions with other factors.
SU(VAR)3–9 interacts with JIL-1
To test whether the interaction between JIL-1 and SU(VAR)3–
9 is mediated by a direct protein-protein contact, we performed
GST-pull down experiments using in vitro translated JIL-1 deletion
mutants and the N-terminal region of SU(VAR)3–9 fused to GST
(Figure 1B) or in vitro translated SU(VAR)3–9 and a GST-JIL-1
fusion protein (Figure 1C). This allowed us not only to verify a
direct interaction between SU(VAR)3–9 and JIL-1 but also to map
the interaction domains between SU(VAR)3–9 and JIL-1 to the N-
terminus of SU(VAR)3–9 and the C-terminus of JIL-1. This is
particularly interesting as mutants lacking the C-terminus of JIL-1
act as suppressors of position effect variegation [27].
Next we wanted to find out whether the two proteins can also
form a complex within living cells. We co-expressed JIL-1 and
SU(VAR)3–9 using a baculoviral expression system (Figure 2A).
As JIL-1 carried a flag- and SU(VAR)3–9 a his-tag we could
verify the formation of a complex using affinity purification.
SU(VAR)3–9 forms a complex with JIL-1 as it was purified using
a flag affinity resin only when flag-JIL-1 was co-expressed
(Figure 2B). This is independent of JIL-1 kinase activity as a
mutant that can no longer phosphorylate histones (JIL-1D392A)
[36] is still able to interact with SU(VAR)3–9 (Figure 2B). As JIL-
1 and SU(VAR)3–9 interact genetically as well as biochemically
we wondered whether the interaction changed the ability of
SU(VAR)3–9 to methylate H3 on lysine 9 (K9). Although the
baculovirally expressed protein is more active than the one
expressed in bacteria (data not shown), we did not observe a
substantial influence of JIL-1 co-expression on SU(VAR)3–9’s
ability to methylate H3 (Figure 2C).
Figure 2. SU(VAR)3–9 and JIL-1 interact in vivo. (A) Coexpression of JIL-1 and SU(VAR)3–9 in SF9 cells using a baculoviral expression system. left:
Western Blot of whole cell Sf9 extract. Proteins were detected using the indicated antibodies. right: Histone methyltransferase assay after co-infection
of SF9 cells with flag-JIL-1 and his-SU(VAR)3–9 followed by affinity purification on a TalonTM metal affinity resin. (B) Precipitation of JIL-1 from an SF9
cell extract co-purifies active SU(VAR)3–9. left: Western Blot analysis of flag-coimmunoprecipitations using SF9 whole cell extract after co-infection
with the indicated viruses. After the Co-IP flag M2-beads were washed and eluted with the flag peptide. 10% of the eluates were separated by SDS
PAGE and analyzed by Western blotting using specific antibodies. right: Histone methyltransferase assay after co-infection of SF9 cells with flag-JIL-1,
a flag-JILD392A and his-SU(VAR)3–9 followed by affinity purification on a flag M2 affinity resin.
doi:10.1371/journal.pone.0010042.g002
or GST SU(VAR)3–9NT together with the indicated JIL-1 constructs. (C) A region within the N-terminus of SU(VAR)3–9 interacts with JIL-1. Top:
Schematic representation of the SU(VAR)3–9 constructs used for the in vitro translation reaction indicating the characteristic domain structure of the
protein (eIF = homology region to the eukaryotic translation initiation factor 2; CD= chromodomain; SET: SET domain). Bottom: GST pull-downs using
bacterial expressed GST or GST JIL-1 full length together with the indicated recombinant SU(VAR)3–9 proteins. The GST fusion proteins were
expressed in E. coli, purified, and incubated with in vitro translated, 35S-labeled JIL-1 or SU(VAR)3–9 (and deletions thereof). I = 5% input used for the
precipitation; G = GST; B = Bound.
doi:10.1371/journal.pone.0010042.g001
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Figure 3. SU(VAR)3–9 is a target for phosphorylation by the chromosomal kinase JIL-1. (A) JIL-1 phosphorylates the N-terminus of
SU(VAR)3–9 in vitro. top: schematic representation of the SU(VAR)3–9 constructs used for the in vitro kinase reaction (WT= SU(VAR)3–9; D152/D213=
N-terminal deletions of 152 or 213 amino acids respectively). Bottom left: in vitro kinase reactions with recombinant and purified GST-JIL-1 (expressed
in SF9 cells using a baculoviral system) and bacterial expressed, affinity purified his-SU(VAR)3–9. Bottom right: As a control reaction Drosophila
histones were analyzed in a kinase assay (+/2 GST-JIL-1). The band labeled with an asterisk corresponds to BSA, which was included in the
purification procedure. (B) The serine 191 of SU(VAR)3–9 (S191) is the major phosphorylation site. top: Amino acid sequence of the putative
phosphorylation domain as determined by the kinase assays in panel (A). The boxed sequence motif indicates a homology to a cAMP kinase
consensus site. bottom: in vitro kinase assay with recombinant and purified flag-JIL-1 and bacterial expressed, affinity purified GST-SU(VAR)3–9 fusion
proteins containing the putative phosphorylation domain (PD: aa 153–208) or a mutation of S191 to A. As a control reaction recombinant Drosophila
histone H3 was assayed in comparison. (C) Specificity of the anti-SU(VAR)3–9-phospho antibody (a-S191ph). Recombinant his-SU(VAR)3–9 was
subjected to an in vitro kinase assay with or without GST-JIL-1 (+/2). After stopping the reaction with SDS-loading buffer, the reactions were
separated by SDS-PAGE followed by Western blotting using a-S191ph and an antibody against SU(VAR)3–9, respectively. (D) SU(VAR)3–9 WT but not
S191A mutant proteins can be phosphorylated by JIL-1. (E) An inactive mutant of JIL-1 (JIL-1D392A) cannot phosphorylate SU(VAR)3–9. SF9 infected
with increasing amounts of the indicated viruses (JIL-1 = flag JIL-1; JIL-1D392A = catalytically inactive form of flagJIL-1 WT = hisSU(VAR)3–9 wild type
protein).
doi:10.1371/journal.pone.0010042.g003
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JIL-1 phosphorylates the N-terminus of SU(VAR)3–9
It has been proposed that the kinase activity of JIL-1 is crucial
for its in vivo function [26,28] and that JIL-1 acts in the same
genetic pathway as SU(VAR)3–9 [30,42]. We therefore tested
whether SU(VAR)3–9 might be a direct substrate of the JIL-1
kinase. In vitro assays showed that JIL-1 can indeed phosphorylate
SU(VAR)3–9 within its N-terminus (Figure 3A). By mutational
analysis we were able to narrowed down the site of phosphory-
lation to amino acids 153–208 (Figure 3A). In order to precisely
map the phosphorylation site within SU(VAR)3–9 we cleaved the
in vitro phosphorylated peptide from the GST moiety with
thrombin and analyzed the phosphorylation product using
MALDI-TOF mass spectrometry (data not shown). Thereby, we
could narrow down the phosphorylation site to amino acids 174–
208. This peptide contains a moderately conserved recognition site
for MSK/RSK kinases, to which JIL-1 belongs (Figure 3B).
Mutation of the serine 191 to alanine (S191A) leads to a protein
that is no longer phosphorylated by JIL-1 (Figure 3B) suggesting
that S191 is the major residue that is phosphorylated by JIL-1.
In order to study the regulation of SU(VAR)3–9 we generated a
phospho S191 (S191ph) specific antibody that recognizes SU(-
VAR)3–9 only after phosphorylation by JIL-1 (Figure 3C). Using
this antibody, we tested whether JIL-1 could phosphorylate
SU(VAR)3–9 in vivo. As the expression levels of SU(VAR)3–9
Figure 4. SU(VAR)3–9 can repress transcription when tethered to a promoter. (A) SU(VAR)3–9 represses transcription in a TSA-dependent
manner. (B) An N-terminal truncation of SU(VAR)3–9 lacking the domain that interacts with JIL-1 and RPD3 can no longer repress transcription. (C)
SU(VAR)3–9’s transcriptional repression capacity is 2 fold reduced in a S191A mutated SU(VAR)3–9. Drosophila SL2 cells were co-transfected with
expression constructs for dorsal and twist and the reporter construct pG5DE5-tkluc together with the indicated plasmids coding for: GAL4-DBD or
GAL4 fusion proteins of SU(VAR)3–9 (and deletions/mutations thereof) and RPD3 in the presence or absence of the histone deacetylase inhibitor
trichostatin A (TSA). left: luciferase assay of the activated reporter gene after transfection with the indicated plasmids. The repression capacity of
GAL4-SU(VAR)3–9 was set to 100% and all other values were normalized accordingly. right: Western Blot analysis of the extracts used for the luciferase
assay using an antibody specific against the GAL4-DBD [G: GAL4 DBD; R: GAL4-Rpd3; S: GAL4- SU(VAR)3–9].
doi:10.1371/journal.pone.0010042.g004
JIL1 Phosphorylates SU(VAR)3–9
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are extremely low in SL2 cells as well as in Drosophila embryos, we
had to resort to an over-expression system. We over-expressed
wild type as well as mutated SU(VAR)3–9 in SF9 cells using
recombinant baculoviruses. Mutation of S191 to either A or E did
not affect the interaction of SU(VAR)3–9 with JIL-1 but prevented
phosphorylation (Figure 3D). Moreover, the phosphorylation was
dependent on active JIL-1 as the catalytically inactive JIL-1D392A
still interacted with SU(VAR)3–9 but was no longer able to
phosphorylate it (Figure 3E).
Phosphorylation of SU(VAR)3–9 does not affect its ability
to repress transcription
To analyze if the phosphorylation had an effect on the
repressive function of SU(VAR)3–9, we used an activated
luciferase reporter system [35] where the repression is mediated
by a GAL4-SU(VAR)3–9 fusion protein. We observed a strong
transcriptional repression by SU(VAR)3–9 (Figure 4), which
depended on the N-terminus of SU(VAR)3–9. A deletion that is
still able to methylate H3 in vitro [31] fails to repress transcription
(Figure 4B). This repressive effect is to a large extent mediated by
an HDAC activity that is recruited to the reporter construct, as we
observed a reduced repression in the presence of an HDAC
inhibitor. This is in agreement with our previous results that show
a genetic interaction between RPD3 and SU(VAR)3–9 [43] and
by observations made in human tissue culture cells [44]. As we
mapped the interaction domain between SU(VAR)3–9 and RPD3
to the N-terminus of SU(VAR)3–9 (Figure 1B) we wondered
whether the transcriptional repression mutation resulted in an
approximately 2-fold reduction of repression at equivalent
expression levels (Figure 4C). However, the major repressive
function appears to be mediated by the recruitment of an HDAC
activity (Figure 4A).
The phosphorylation of SU(VAR)3–9 in vivo is dependent
on JIL-1
To investigate if SU(VAR)3–9 is phosphorylated by JIL-1 in
Drosophila cells as well as in flies we used the phospho-specific
antibody to stain SL2 cells in which endogenous JIL-1 had been
Figure 5. SU(VAR)3–9 is phosphorylated by JIL-1 in vivo. (A) SL2 cells were subjected to either control RNAi (GST) or JIL-1 RNAi and transfected
with Gal4-SU(VAR)3–9wt or Gal4-SU(VAR)S191A. Monoclonal antibodies specific for SU(VAR)3–9 detect the protein only in the transfected cells.
S191ph signal is associated with the overexpressed Gal4-SU(VAR)3–9 in the control GST RNAi but not after JIL-1 RNAi. (B) Quantification of 2
independent experiments showed that no S191ph signal is associated with Gal4-SU(VAR)S191A overexpressing cells (n = 192). 48% of the cells
expressing Gal4-SU(VAR)wt have a S191ph signal in GST control RNAi (n = 303), and only 27% after JIL-1 RNAi (n = 311). (C) Phosphorylation of
SU(VAR)3–9 by co-tethering of lacI-SU(VAR)3–9 and lacI-JIL-1 fusion proteins. The panels represent triple labelings of polytene squash preparations
from third instar larvae homozygous for the lacO repeat line P11.3. LacI-SU(VAR)3–9 and LacI-JIL-1 were tethered to the lacO repeats in the upper
panel and LacI-SU(VAR)3–9 with a catalytically inactive LacI-JIL-1 in the lower panel. LacI antibody labeling is shown in green, 3–9ph antibody labeling
in red, and Hoechst labeling of DNA in blue or grey. The white arrows indicate the lacO repeat insertion site. Top: At the lacO repeat insertion site
where LacI-SU(VAR)3–9 and LacI-JIL-1 are co-tethered there is robust phosphorylation of LacI-SU(VAR)3–9 as detected by the S191ph antibody.
Bottom: In contrast, when LacI-SU(VAR)3–9 is co-tethered with an inactive LacI-JIL-1 construct there is no or little phosphorylation of LacI-SU(VAR)3–9
detectable by the S191ph antibody. Note: In additon to the lacO tethering site the LacI constructs also localize to their endogenous chromatin
binding sites as shown by the localization of LacI-JIL-1 to interband regions.
doi:10.1371/journal.pone.0010042.g005
JIL1 Phosphorylates SU(VAR)3–9
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depleted by RNA interference (RNAi) and were subsequently
transfected with an expression construct for GAL-SU(VAR)3–9
(Figure 5A). In control cells (treated with a control dsRNA
containing the GST sequence) 48% of all cells that stained
positive for GAL4-SU(VAR)3–9 also showed an immunofluores-
cence signal with the S191ph antibody (Figure 5B). Upon RNA
interference against JIL-1 the fraction of phosphorylated
SU(VAR)3–9 dropped to 27% suggesting that although JIL-1 is
a major kinase for this site other kinases may also phosphorylate
the N-terminus of SU(VAR)3–9. When the S191A mutant was
expressed no signal was detected using the S191ph antibody,
further demonstrating the specificity of the antibody (Figure 5B).
Finally we wanted to know if SU(VAR)3–9 was phosphorylated
by JIL-1 when both proteins are co-tethered to an ectopic binding
site in vivo. Towards this end we used a fly strain that carried
multiple lacO tandem repeat binding sites for the LacI repressor
stably integrated on the third chromosome as described in [36].
We generated transgenic fly lines that expressed both SU(-
VAR)3–9 and JIL-1 LacI fusion proteins to ensure that both
proteins were targeted to the lacO repeats. Staining polytene
chromosomes of these larvae with the S191ph antibody we
observed a strong labelling at the tethering site (Figure 5C). The
phosphorylation of SU(VAR)3–9 at this locus was dependent on a
functional JIL-1 kinase, because the targeting of an inactive JIL-1
enzyme greatly reduced the labelling by the S191ph antibody
(Figure 5C).
Discussion
In this work we describe the isolation and characterisation of a
novel interactor for SU(VAR)3–9. Using the N-terminal dimer-
ization domain as a bait we identified the chromosomal kinase JIL-
1 as a SU(VAR)3–9 binding protein. The direct protein-protein
interaction is mediated by the C-terminus of JIL-1. A deletion of
this interaction domain in JIL-1 leads to a suppression of position
effect variegation in flies [27], suggesting that the interaction
between the two factors influences heterochromatic spreading.
This interaction leads to a phosphorylation of SU(VAR)3–9 by
JIL-1 at position S191 in vitro and in vivo. We did not observe an
increase in HMT activity after phosphorylation of SU(VAR),
which is consistent with the fact that a mutation of JIL-1 does not
alter global H3K9 methylation [30]. In transiently transfected
reporter assays we see a strong influence of SU(VAR)3–9’s N-
terminus on transcriptional repression, which is mainly dependent
on the recruitment of a histone deacetylase activity and is only
moderately affected by the JIL-1 mediated phosphorylation. Our
results suggest that the N-terminus of SU(VAR)3–9 may serve as a
platform that integrates several incoming signals via multiple
interactions.
A null mutation of JIL-1 leads to a global disruption of
chromatin structure [28,29]. This has been mainly attributed to a
lack of H3S10 phosphorylation and an extensive spreading of
heterochromatin in the absence of JIL-1. SU(VAR)3–9 spreads to
euchromatic regions in a JIL-1z2/z2 homozygous mutant back-
ground [42] placing Su(var)3–9 and JIL-1 in the same genetic
pathway. The defects of chromosome morphology that can be
seen in homozygous JIL-1z2/z2 mutant larvae can at least partly be
rescued by crossing JIL-1 mutant flies to a Su(var)3–9 hypomor-
phic genetic background [30]. This effect is not observed in an
HP1 mutant background (Su(var)2–5), which suggests that it is
independent of the classical heterchromatin assembly. SU(VAR)3–
9 or its mammalian orthologs interact with multiple other proteins
[43,44,45,46,47,48,49,50] in many cases via the N-terminus.
Many of these interactions are important for the function of
SU(VAR)3–9 as transcriptional repressor outside of its classical
role in establishing heterochromatin. At the same time, the N-
terminus of Drosophila as well as mammalian SU(VAR)3–9 serves
as a heterochromatin-targeting module [51,52], which suggests
that this domain plays a central role in regulating SU(VAR)3–9’s
function in vivo.
The N-terminus of the mammalian ortholog, SUV39H1, has
been shown to be phosphorylated in mammalian cells [15] but
neither the kinase nor the function of the phosphorylation was
determined. Our finding that this crucial domain is phosphory-
lated in vitro and in vivo by an enzyme that interacts genetically with
Su(var)3–9 [27,30] provides a possible molecular explanation for
the genetic interaction. However, we neither observed a strong
effect on the HMT activity of the enzyme nor did we see a strong
reduction in SU(VAR)3–9’s ability to repress transcription in a
transient reporter assay. This may reflect the current model
according to which the interaction between JIL-1 and SU(VAR)3–
9 plays a role only at distinct genomic loci such as the boundary
regions between heterochromatin and euchromatin [27]. At such
specific regions the phosphorylation and/or the interaction may
change the affinity of the SU(VAR)3–9 N-terminus for its specific
interactors thereby fine-tuning the molecular composition of
SU(VAR)3–9 containing complexes. It will be interesting to
further study several SU(VAR)3–9 interactors and investigate how
the phosphorylation regulates their binding to the SU(VAR)3–9
N-terminus.
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